Harlan Laboratories Continues Global Growth
News May 09, 2013
This expansion more than doubles the number of isolators at these sites allowing Harlan to meet growing customer demand for its immunocompromised models.
"Our investment in these facilities underscores our commitment to providing the highest quality research models and services to investigators across the globe," said Joe Meyer , Vice President Global Commercial Operations at Harlan Laboratories. "We will continue to expand and enhance our facilities worldwide to meet the needs of the research community in key therapeutic research areas like oncology, immunology and toxicology with consistently dependable research models, diets and supporting services."
These facilities incorporate the latest technology and design advances to ensure sustained high health status research models. The environmentally controlled breeding isolators are supported by individual air supply and HEPA filtered air handling to ensure the integrity of the colony housed within each isolator. The facilities also feature the latest state-of-the-art equipment and biosecurity measures including a watering system with automatic flushing to help prevent the unwanted proliferation of organisms, as well as a whole building redundant backup power system.
The expansion extends beyond an increase in facility footprint. Harlan Laboratories incorporated several sustainable components to the newly renovated Indianapolis and Livermore facilities.
"We designed the facilities with a dual purpose - animal care and sustainability. We have incorporated energy efficient lighting and water systems, as well as designed workflows to support our biosecurity practices," said Mike Lipke , Global Vice President of Operations at Harlan Laboratories. "We are very proud of these two additions to the Harlan network and look forward to our ability to meet increasing customer demand from these state-of-the-art facilities."
Cold and Flu Season is Well Under Way But Don't Stifle a Sneeze Warn DoctorsNews
Pinching your nose while clamping your mouth shut to contain a forceful sneeze isn't a good idea, warn doctors. One young man managed to rupture the back of his throat during this manoeuvre, leaving him barely able to speak or swallow, and in considerable pain.READ MORE
Immunosuppressive Cells in Newborns Play Important Role in Controlling Inflammation in Early LifeNews
New research has characterized the transitory presence of myeloid-derived suppressor cells (MDSCs) in mouse and human newborns, revealing a critical role of these cells in regulation of inflammation in the early stages of life.READ MORE
Fast-tracking T Cell Therapies with Immune-mimicking BiomaterialsNews
A new approach to amplify patient-specific T cells outside the body could increase the efficiency of cancer immunotherapies.READ MORE